Clinical Trial Update: A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers [Phase 2, Phase 3]

View source ↗

Summary

A dual-phase (Phase 2/3) trial evaluating beta-glucan or a beta-glucan compound in metastatic cancer patients undergoing chemotherapy; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Beta Glucan (beta-glucan)

Snippet

Sponsor: E-DA Hospital | Conditions: Metastatic Cancer, Chemotherapy | Phase 2, Phase 3 | Status: UNKNOWN